Myo-Inositol for PCOS: Meta-Analysis
Reproductive BioMedicine Online (2017)
Myo-inositol (4g/day) significantly improved ovulation rate, reduced androgens, and improved insulin sensitivity in PCOS women.
Inositol (Myo- & D-Chiro-Inositol)
PowderAvailable in all 50 statesMarketing purposes only. Actual medications, if prescribed, are dispensed by a licensed pharmacy.
women's health
Inositol (Myo- & D-Chiro-Inositol)Inositol (Myo- & D-Chiro-Inositol)
Combination of myo-inositol and D-chiro-inositol used primarily for PCOS management. These insulin-sensitizing agents improve ovarian function, reduce androgen levels, and support metabolic health in PCOS.
Improves insulin sensitivity
Restores ovulation in PCOS
Reduces androgen levels
Improves oocyte quality
No commitment · HSA/FSA eligibleNo commitment · HSA/FSA eligible
How it works
Mechanism of action
Myo-inositol is a second messenger in insulin signaling (via IP3 pathway) and FSH signaling in the ovary. D-chiro-inositol mediates insulin's glycogen synthesis effects. Together they improve insulin sensitivity and restore ovarian steroidogenic function.
The baseline panel.
Every Marek client receives this baseline panel before a provider review. Your provider may add additional biomarkers based on your health history, symptoms, and goals, pulling from 1,000+ available markers. See more biomarkers →
Hormone Profile
12 markers
Sex hormones
- Total TestosteroneLC/MS
- Free TestosteroneEquilibrium Dialysis
- Estradiol, Sensitive / UltrasensitiveLC/MS
- Sex Hormone Binding Globulin (SHBG)
- ProgesteroneLC/MSFemale panel
- Prolactin
- Luteinizing Hormone (LH)
- Follicle-Stimulating Hormone (FSH)
- hCG, Total, QuantitativeFemale panel, pre-menopause
Adrenals & neurosteroids
- Cortisol
- DHEA-S
Growth hormone / IGF-1
- Insulin-Like Growth Factor I (IGF-1)
Thyroid Status
3 markers
Thyroid hormones
- Thyroid Stimulating Hormone (TSH)
- Free T4
- Free T3
Heart Health
9 markers
Cardiovascular health
- Total Cholesterol
- HDL Cholesterol
- LDL Cholesterol
- LDL:HDL Ratio
- VLDL Cholesterol
- Triglycerides
- Apolipoprotein-B (ApoB)
- C-Reactive Protein, High Sensitivity (hsCRP)
- Lipoprotein(a) (Lp(a))
Metabolism
3 markers
Insulin sensitivity
- Blood Glucose
- Fasting Insulin
- HbA1c
Organ Function
26 markers
Liver & pancreas
- AST
- ALT
- Bilirubin, Total
- γ-Glutamyl Transferase (GGT)
Kidney function
- BUN
- Creatinine w/ eGFR
Comprehensive Metabolic Panel (CMP)
- Glucose
- Blood Urea Nitrogen (BUN)
- Creatinine
- eGFR
- BUN/Creatinine Ratio
- Sodium
- Potassium
- Chloride
- Carbon Dioxide, Total
- Calcium
- Protein, Total
- Albumin
- Globulin, Total
- Albumin/Globulin (A/G) Ratio
- Alkaline Phosphatase (ALP)
- AST
- ALT
Prostate health
- Prostate-Specific Antigen (PSA)Male panel
- Free PSAMale panel
- % Free PSAMale panel
Nutrient Status
31 markers
Vitamins & minerals
- Vitamin D, 25-OHD (25-Hydroxy)
- Magnesium, RBC
Iron status
- Iron
- Iron Saturation
- TIBC
- UIBC
- Ferritin
Complete Blood Count (CBC)
- White Blood Count (WBC)
- Red Blood Count (RBC)
- Hemoglobin (Hgb)
- Hematocrit (HCT)
- MCV
- MCH
- MCHC
- Red Cell Distribution Width (RDW)
- Platelets
- Neutrophils
- Neutrophils (Absolute)
- Lymphocytes
- Lymphocytes (Absolute)
- Neutrophil/Lymphocyte Ratio
- Monocytes
- Monocytes (Absolute)
- Eosinophils
- Eosinophils (Absolute)
- Basophils
- Basophils (Absolute)
- Immature Cells
- Immature Granulocytes
- Immature Granulocytes (Absolute)
- NRBC, w/ Reflex for Immature Cells
Clinical evidence
The research behind Inositol (Myo- & D-Chiro-Inositol).
Safety profile
Monitoring & safety information.
Commonly reported side effects
- Nausea (mild)
- Bloating
- Flatulence
- Insomnia (rare)
Less common but serious risks
- None significant at standard doses
Generally not appropriate for
- None established
Typical monitoring
- Fasting glucose and insulin
- Testosterone (total and free)
- Menstrual cycle regularity
- SHBG
FAQ
Quick answers.
Combination of myo-inositol and D-chiro-inositol used primarily for PCOS management. These insulin-sensitizing agents improve ovarian function, reduce androgen levels, and support metabolic health in PCOS.
Improves insulin sensitivity. Restores ovulation in PCOS. Reduces androgen levels. Improves oocyte quality. Well tolerated.
Common side effects include: nausea (mild), bloating, flatulence, insomnia (rare). Most side effects are dose-dependent and may resolve with continued use or dose adjustment.
Combination of myo-inositol and D-chiro-inositol used primarily for PCOS management. These insulin-sensitizing agents improve ovarian function, reduce androgen levels, and support metabolic health in PCOS.
Treatments are dependent on licensed clinical prescription. Client costs vary based on individual labs and panel in treatments and services.